Compounds > glucagon
Page last updated: 2024-09-04

glucagon and Multiple Endocrine Neoplasia Type 1

glucagon has been researched along with Multiple Endocrine Neoplasia Type 1 in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (21.43)18.2507
2000's6 (42.86)29.6817
2010's5 (35.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, GY; Kim, S; Ong, RKS; Shawa, H1
Bisschop, PH; de Herder, WW; de Laat, JM; Dekkers, OM; Drent, ML; Havekes, B; Hermus, AR; Pieterman, CR; Valk, GD; van der Horst-Schrivers, AN; Vriens, MR; Weijmans, M1
Hyo, T; Imamura, M; Kawai, J; Komoto, I; Kurose, T; Kuwata, H; Miura, Y; Nagamatsu, T; Rokutan, M; Seino, Y; Shimizu, S; Usui, R; Watanabe, K; Yabe, D1
Bassett, RL; Cao, L; Christakis, I; Gardner Grubbs, E; Lee, JE; Meng, QH; Perrier, ND; Qiu, W; Silva, A; Yao, JC; Zhao, H1
Bao, X; Chen, Y; Gao, Z; Guo, Y; Hu, Q; Jin, G; Wang, S; Wang, Z; Xie, W; Xue, M; Zhang, H; Zhang, L1
Bedossa, P; Belghiti, J; Corcos, O; Couvelard, A; Giraud, S; Hammel, P; Larochelle, O; Périgny, M; Richard, S; Ruszniewski, P; Sauvanet, A1
Aozasa, K; Funahashi, T; Hayashi, I; Iwahashi, H; Kato, K; Katsube, F; Kim, T; Kizu, T; Matsuhisa, M; Miyagawa, J; Nakamori, S; Nammo, T; Okauchi, Y; Okita, K; Osuga, K; Shimomura, I; Tamaki, Y; Uno, S; Yamagata, K1
Arita, Y; Ito, T1
Baudin, E; Cadiot, G; Cardot-Bauters, C; Chabre, O; Choplin, Hdu B; Delemer, B; Jovenin, N; Levoir, D; Murat, A; Niccoli-Sire, P; Penfornis, A; Thomas-Marques, L1
Thompson, JC; Townsend, CM1
Ishizuka, T; Itakura, M; Kamura, M; Okumura, S; Saji, S; Sarui, H; Shimokawa, K; Takao, H; Takuno, H; Yasuda, K; Yoshimoto, K1
Bishof-Delaloye, A; Centeno, G; Chaubert, P; Francke, ML; Gomez, F; Haefliger, JA; Nicod, P; Scherrer, U; Temler, E; Waeber, G1
Kihara, M; Kobayashi, S; Miyauchi, A; Murao, K; Nishitani, A; Sato, M; Takahara, J1
Dietze, O; Hacker, GW; Hauser-Kronberger, C; Sattlegger, P; Sungler, P; Weitgasser, R1

Reviews

3 review(s) available for glucagon and Multiple Endocrine Neoplasia Type 1

ArticleYear
Simultaneous Glucagon and Vasoactive Intestinal Peptide Producing Pancreatic Neuroendocrine Tumors in a Patient With Multiple Endocrine Neoplasia Type 1: A Case Report and Literature Review.
    Pancreas, 2018, Volume: 47, Issue:1

    Topics: Aged; Diabetes Mellitus, Type 2; Glucagon; Humans; Male; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Splenectomy; Treatment Outcome; Vasoactive Intestinal Peptide

2018
[Diagnosis and treatment of insulinoma].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:4

    Topics: Antineoplastic Agents; Blood Glucose; Chemoembolization, Therapeutic; Diazoxide; Fasting; Glucagon; Humans; Insulinoma; Magnetic Resonance Imaging; Maleic Anhydrides; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Polystyrenes; Somatostatin; Tomography, X-Ray Computed; Zinostatin

2004
The clinical use of gastrointestinal hormones for alimentary tract disease.
    Advances in surgery, 1996, Volume: 29

    Topics: Adenoma, Islet Cell; Cholecystokinin; Digestive System Diseases; Gastrointestinal Hormones; Glucagon; Glucagonoma; Humans; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Pancreatic Polypeptide; Somatostatin; Somatostatinoma; Vipoma; Zollinger-Ellison Syndrome

1996

Other Studies

11 other study(ies) available for glucagon and Multiple Endocrine Neoplasia Type 1

ArticleYear
Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:10

    Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Chromogranin A; Female; Glucagon; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Pancreatic Neoplasms; Pancreatic Polypeptide

2013
Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo.
    Diabetes research and clinical practice, 2013, Volume: 102, Issue:1

    Topics: Adult; Arteries; Calcium Gluconate; Food; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucagonoma; Humans; Injections, Intra-Arterial; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Pancreatectomy

2013
Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
    Clinical endocrinology, 2016, Volume: 85, Issue:3

    Topics: Adolescent; Adult; Aged; Area Under Curve; Biomarkers, Tumor; Chromogranin A; Female; Gastrins; Glucagon; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Pancreatic Neoplasms; Pancreatic Polypeptide; Retrospective Studies; Young Adult

2016
Male Men1 heterozygous mice exhibit fasting hyperglycemia in the early stage of MEN1.
    The Journal of endocrinology, 2016, Volume: 230, Issue:3

    Topics: Animals; Fasting; Glucagon; Gluconeogenesis; Heterozygote; Hyperglycemia; Insulin Resistance; Islets of Langerhans; Liver; Male; Mice; Mice, Mutant Strains; Multiple Endocrine Neoplasia Type 1

2016
Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.
    The American journal of surgical pathology, 2009, Volume: 33, Issue:5

    Topics: Adenoma; Adult; Antigens, CD34; Antigens, Neoplasm; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Chromogranin A; Cyclin D1; Female; Glucagon; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Insulin; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Mutation; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Precancerous Conditions; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein

2009
Glucagonoma diagnosed by arterial stimulation and venous sampling (ASVS).
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:12

    Topics: Aged; Calcium; Female; Glucagon; Glucagonoma; Humans; Multiple Endocrine Neoplasia Type 1; Mutation; Pancreatic Neoplasms

2009
Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
    The American journal of gastroenterology, 2006, Volume: 101, Issue:2

    Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Diagnosis, Differential; Disease Progression; Duodenal Neoplasms; Endosonography; Female; Follow-Up Studies; Gastrins; Glucagon; Humans; Incidence; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Pancreatic Polypeptide; Peptides; Prospective Studies; Severity of Illness Index; Vasoactive Intestinal Peptide

2006
Cystic glucagonoma with loss of heterozygosity on chromosome 11 in multiple endocrine neoplasia type 1.
    Clinical endocrinology, 1997, Volume: 46, Issue:4

    Topics: Arginine; Chromosomes, Human, Pair 11; Glucagon; Glucagonoma; Glucose Tolerance Test; Homozygote; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Ultrasonography

1997
Insulinoma associated with a case of multiple endocrine neoplasia type I: Functional somatostatin receptors and abnormal glucose-induced insulin secretion.
    Hormone research, 1997, Volume: 48, Issue:2

    Topics: Actins; Adolescent; Dose-Response Relationship, Drug; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Glucagon; Glucose; Glucose Transporter Type 1; Hormones; Humans; Hyperparathyroidism; Immunohistochemistry; Injections, Intravenous; Insulin; Insulin Secretion; Insulinoma; Male; Monosaccharide Transport Proteins; Multiple Endocrine Neoplasia Type 1; Octreotide; Pancreatic Neoplasms; Parathyroid Neoplasms; Receptors, Somatostatin; RNA, Messenger; Tomography, Emission-Computed, Single-Photon

1997
Large and asymptomatic pancreatic islet cell tumor in a patient with multiple endocrine neoplasia type 1.
    Endocrine, 2000, Volume: 13, Issue:3

    Topics: Adenoma, Islet Cell; Aged; Angiography; Gastrins; Germ-Line Mutation; Glucagon; Humans; Hyperparathyroidism; Immunohistochemistry; Insulin; Magnetic Resonance Imaging; Male; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Parathyroidectomy; Serotonin; Spleen

2000
Immunohistochemical assessment of an asymptomatic glucagonoma in a patient with hypergastrinemia and marked antral angiodysplasia.
    Applied immunohistochemistry & molecular morphology : AIMM, 2001, Volume: 9, Issue:1

    Topics: Diagnosis, Differential; Gastric Antral Vascular Ectasia; Gastrins; Glucagon; Glucagonoma; Humans; Immunohistochemistry; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Pyloric Antrum

2001